5-methylcytosine has been researched along with Lymphoma, Large B-Cell, Diffuse in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cen, X; Ou, J; Shen, Y; Wang, B; Wang, L | 1 |
| Bracci, PM; Chiu, BC; He, C; Smith, SM; Stepniak, E; Venkataraman, G; You, Q; Yu, K; Zeng, C; Zhang, W; Zhang, Z | 1 |
| Chen, HY; Chen, L; He, C; He, XH; Hong, Y; Jing, HM; Li, F; Li, W; Lin, J; Liu, H; Liu, J; Pang, M; Qin, Y; Wang, J; Xiao, XB; Xu, N; Yan, C; Yang, P; Yang, ZR; Zhang, L; Zhang, WL; Zhu, HC | 1 |
3 other study(ies) available for 5-methylcytosine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Testicular Neoplasms; Testis | 2022 |
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cell-Free Nucleic Acids; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prognosis; Prospective Studies; Young Adult | 2019 |
5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients.
Topics: 5-Methylcytosine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Cell-Free Nucleic Acids; Cohort Studies; Cyclophosphamide; DNA Demethylation; Doxorubicin; Female; Humans; Logistic Models; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Predictive Value of Tests; Prednisone; Rituximab; Sensitivity and Specificity; Vincristine | 2021 |